Table 2.
All patients (n = 123) | Mild/moderate MIS-C (n = 75) | Severe MIS-C (n = 48) | p value | ||
---|---|---|---|---|---|
Echocardiography n (%) | |||||
LV dysfunction | 45 (36.6) | 13 (17.3) | 32 (66.7) | < 0.001a | |
Valve failure | 58 (47.2) | 25 (33.3) | 33 (68.8) | < 0.001a | |
Pericardial effusion | 31 (25.2) | 12 (16) | 19 (39.6) | 0.003a | |
Coronary involvement | 14 (11.4) | 11 (14.7) | 3 (6.3) | 0.15a | |
Myocarditis | 6 (4.9) | 0 (0) | 6 (12.5) | 0.003b | |
LVEF (%)* | 65 (58–70) | 68 (64–72) | 58.5 (52–65.8) | < 0.001 c | |
LVEF n (%) | 0.001a | ||||
30–44 | 2 (1.6) | 0 (0) | 2 (4.2) | ||
45–54 | 20 (16.3) | 6 (8) | 14 (29.2) | ||
> 55 | 101 (82.1) | 69 (92) | 32 (66.7) | ||
Abdominal ultrasonographyc n (%) | |||||
Bowel wall thickening | 28 (27.2) | 15 (25) | 13 (30.2) | 0.56a | |
Lymphadenopathy | 42 (40.8) | 25 (41.7) | 17 (39.5) | 0.83a | |
Ascites | 48 (46.6) | 21 (35) | 27 (62.8) | 0.005a | |
Mesenteric inflammation | 16 (15.5) | 8 (13.3) | 8 (18.6) | 0.47a | |
Appendicitis findings | 10 (9.7) | 8 (13.3) | 2 (4.7) | 0.19b | |
Hepatosplenomegaly | 11 (10.7) | 7 (11.7) | 4 (9.3) | 0.76b |
*Median (ınterquartile range)
aChi-square
bFisher’s exact test
c20 patient not available for assessment
LV, left ventricle, LVEF, left ventricular ejection fraction